The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Cladribine in treatment of chronic progressive multiple sclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SNEDECOR, G. W. (1939) · Soil Science · doi:10.1097/00010694-193902000-00006 · Cited by 19,359
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Weighted kappa: nominal scale agreement provision for scaled disagreement or partial credit
Cohen, J. (1968) · Psychological Bulletin · doi:10.1037/h0026256 · Cited by 8,736
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Paty, D. W., Li, D. K. B., the UBC MS/MRI Study Group, & the IFNB Multiple Sclerosis Study Group (1993) · Neurology · doi:10.1212/wnl.43.4.662 · Cited by 1,967
Immunobiology and Pathogenesis of Hepatocellular Injury in Hepatitis B Virus Transgenic Mice
Moriyama, T., Guilhot, S., Klopchin, K., Moss, B., Pinkert, C. A., Palmiter, R. D., Brinster, R. L., Kanagawa, O., & Chisari, F. V. (1990) · Science · doi:10.1126/science.1691527 · Cited by 366
Cladribine (2-chlorodeoxyadenosine)
Beutler, E. (1992) · The Lancet · doi:10.1016/0140-6736(92)92826-2 · Cited by 348
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes
Carson, D., Wasson, D., Taetle, R., & Yu, A. L.-T. (1983) · Blood · doi:10.1182/blood.v62.4.737.737 · Cited by 276
A neurologic rating scale (NRS) for use in multiple sclerosis
Sipe, J. C., Knobler, R. L., Braheny, S. L., Rice, G. P. A., Panitch, H. S., & Oldstone, M. B. A. (1984) · Neurology · doi:10.1212/wnl.34.10.1368 · Cited by 255
Self-citationGoodkin, D. E., Cookfair, D., Wende, K., Bourdette, D., Pullicino, P., Scherokman, B., & Whitham, R. (1992) · Neurology · doi:10.1212/wnl.42.4.859 · Cited by 212
Cited by
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
Ioannidis, J. P. A. (2005) · JAMA · doi:10.1001/jama.294.2.218 · Cited by 1,465
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Giovannoni, G., Comi, G., Cook, S., Rammohan, K., Rieckmann, P., Sørensen, P. S., Vermersch, P., Chang, P., Hamlett, A., Musch, B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902533 · Cited by 1,023
Li, D. K. B., Paty, D. W., & UBC MS/MRI Analysis Research Group and the PRISMS Study Group (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<197::aid-ana9>3.0.co;2-p · Cited by 380
Cladribine and progressive MS: Clinical and MRI outcomes of a multicenter controlled trial
Rice, G. P. A., Filippi, M., Comi, G., & for the Cladribine Clinical Study Group and for the Cladribine MRI Study Group* (2000) · Neurology · doi:10.1212/wnl.54.5.1145 · Cited by 325
Metadata
- Authors
- SIPE, J.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1994-07
- Volume
- 344
- Issue
- 8914
- Pages
- 9-13
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W1981220317
- Cited by
- 283
- References
- 13
- FWCI
- 14.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cladribine in treatment of chronic progressive multiple sclerosis. https://app.cochat.ai/papers/10.1016/s0140-6736(94)91046-4
- The paper
- SIPE, J. (1994). Cladribine in treatment of chronic progressive multiple sclerosis. The Lancet. https://doi.org/10.1016/s0140-6736(94)91046-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.